Clinical Trials in Philadelphia

Showing 5621-5640 of 20,904 trials

A Physical Activity Intervention to Promote Cognitive Health, Cardiovascular Health and Sleep in Older Latinos

NCT05030948

This study is a randomized, single-blind, controlled trial that will test a multilevel intervention, Tiempo Juntos para la Salud, (Time Together for Health) designed to promote moderate-intensity physical activity; theoretically grounded mediators; and secondary outcomes of cardiovascular health, sleep and cognitive function. Participants will have 4 visits over a year long period. Data collection will occur at baseline, 3 months, 6 months, and 12 months among 216 Spanish language-dominant Latinos aged 55 and older with Mild Cognitive Impairment (MCI) \[Montreal Cognitive Assessment (MoCA) score 23 to 26 for Latino populations\].

Mild Cognitive Impairment

University of Pennsylvania236 participantsStarted Aug 2021

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

NCT05560646

The purpose of this global Phase 2 study is to determine the efficacy, safety, and tolerability of 3 dose levels of OG-6219 in pre-menopausal women between 18 and 49 years of age (inclusive), who have moderate to severe endometriosis-related pain.

Endometriosis

Organon and Co354 participantsStarted Oct 2022

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Los Angeles, California, United States +83 more locations

A Physical Activity Intervention to Promote Cognitive Health, Cardiovascular Health and Sleep in Older Latinos

A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Find Trials by Condition in Philadelphia

Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy

Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

SPIROMICS Study of Early COPD Progression (SOURCE)

Randomized Therapy In Status Epilepticus

An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism

Flexiva Pulse Registry

Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study

Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation

HEALing Communities Study

Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced Alopecia

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

Modifiers of Disease Severity in Cerebral Cavernous Malformations

A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients